Multiple Executives Engaged in Stock Sale and Tax Withholding Transactions at Amgen.
Amgen executives, including the SVP & CCO and several EVPs, engaged in various stock sale and tax withholding transactions. These actions involved the sale of shares and utilization of existing shares for tax obligations. The exact amount of stock sold and the executives involved were disclosed in the reports.
Multiple Amgen executives have recently engaged in transactions involving the sale of company stock and the use of shares for tax withholding. On May 6, 2026, SVP & CCO Nancy Grygiel sold $400,450 of company stock. Additionally, several other executives reported the sale of shares. SVP Robert A. Bradway's representative sold 1,237 shares, although this was partially covered by retained shares. EVP Reese sold 1,433 shares for tax purposes. CFO Scott A. Foran has also recorded equity taxes by withholding shares, although specific details remain unclear. EVPs Esteban Santos and others made similar moves, but the reports lack detailed information [docs 9, 11].
Related Stocks
Powered by SentiSense - Intelligent Market Analysis